Introduction: Chronic kidney disease (CKD) and heart failure with preserved ejection fraction (HFpEF) are more prevalent in the elderly. There is a lack of large animal models that allow the study of the impact of age on CKD and HFpEF in a translational fashion. This manuscript reports the first large preclinical model of CKD-HFpEF and metabolic derangements in naturally aged swine. Methods: CKD-HFpEF was induced in naturally aged (6–9 years old) and young (3 months old) pigs, followed for 14 weeks, and compared to normal young and old controls (n = 5/group). Renal and cardiac hemodynamics were quantified in vivo by multidetector-CT, echocardiography, and pressure-volume relationship studies. Renal and cardiac microvascular (MV) architecture (3D-micro-CT) and morphometric analysis (staining) were investigated ex vivo. Results: Both young and old pigs developed CKD-HFpEF, but the renal, cardiac, and metabolic phenotype was accentuated in aging animals. Aging and CKD-HFpEF influenced fasting insulin levels and insulin resistance, glomerular filtration rate, cortical MV density, glomerulosclerosis, perivascular fibrosis, and tubular injury. Tubule-interstitial fibrosis and peritubular capillary density were influenced by aging, CKD-HFpEF, and their interaction (2-way ANOVA). Similarly, cardiac MV density, perivascular fibrosis, and myocardial remodeling were influenced by aging and CKD-HFpEF, and E/A by their interaction. Notably, renal and cardiac MV density correlated with renal and cardiac functional and structural changes. Conclusion: Our study establishes the first large animal model of aging CKD-HFpEF, allowing the investigation of age as a biological variable in cardiorenal and metabolic diseases. This new platform could foster new age-related research toward developing therapeutic interventions in CKD-HFpEF.

1.
Jankowski
J
,
Floege
J
,
Fliser
D
,
Bohm
M
,
Marx
N
.
Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options
.
Circulation
.
2021
;
143
(
11
):
1157
72
.
2.
U.S. Renal data system U, annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States NIoH
.
National Institute of Diabetes and Digestive and Kidney Diseases
.
Bethesda, MD
.
2018
. p.
2018
.
3.
National Institute of Diabetes and Digestive and Kidney Diseases NIoH
.
US department of health and human services. United states renal data system. 2020 USRDS annual data report: epidemiology of kidney disease in the United States
.
2020
.
4.
Centers for Disease Control and Prevention UDoHaHS. Centers for Disease Control and Prevention
.
Chronic kidney disease in the United States
.
2021
.
5.
Rao
MV
,
Qiu
Y
,
Wang
C
,
Bakris
G
.
Hypertension and CKD: kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES), 1999-2004
.
Am J Kidney Dis
.
2008
;
51
(
4 Suppl 2
):
S30
37
.
6.
Shah
KS
,
Fang
JC
.
Is heart failure with preserved ejection fraction a kidney disorder
.
Curr Hypertens Rep
.
2019
;
21
(
11
):
86
.
7.
Tsao
CW
,
Aday
AW
,
Almarzooq
ZI
,
Alonso
A
,
Beaton
AZ
,
Bittencourt
MS
, et al
.
Heart disease and stroke statistics-2022 update: a report from the American heart association
.
Circulation
.
2022
;
145
(
8
):
e153
639
.
8.
Cai
QZ
,
Lu
XZ
,
Lu
Y
,
Wang
AY
.
Longitudinal changes of cardiac structure and function in CKD (CASCADE study)
.
J Am Soc Nephrol
.
2014
;
25
(
7
):
1599
608
.
9.
Park
M
,
Hsu
CY
,
Li
Y
,
Mishra
RK
,
Keane
M
,
Rosas
SE
, et al
.
Associations between kidney function and subclinical cardiac abnormalities in CKD
.
J Am Soc Nephrol
.
2012
;
23
(
10
):
1725
34
.
10.
Escoli
R
,
Carvalho
MJ
,
Cabrita
A
,
Rodrigues
A
.
Diastolic dysfunction, an underestimated new challenge in dialysis
.
Ther Apher Dial
.
2019
;
23
(
2
):
108
17
.
11.
Streng
KW
,
Nauta
JF
,
Hillege
HL
,
Anker
SD
,
Cleland
JG
,
Dickstein
K
, et al
.
Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction
.
Int J Cardiol
.
2018
;
271
:
132
9
.
12.
Ter Maaten
JM
,
Damman
K
,
Verhaar
MC
,
Paulus
WJ
,
Duncker
DJ
,
Cheng
C
, et al
.
Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation
.
Eur J Heart Fail
.
2016
;
18
(
6
):
588
98
.
13.
Namoos
K
,
Huang
CW
,
Liu
ILA
,
Lee
JS
,
Yi
DK
,
Sim
JJ
.
Rates of heart failure with preserved ejection fraction in CKD
.
Clin J Am Soc Nephrol
.
2024
;
19
(
7
):
911
3
.
14.
Lekavich
CL
,
Barksdale
DJ
,
Neelon
V
,
Wu
JR
.
Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
.
Heart Fail Rev
.
2015
;
20
(
6
):
643
53
.
15.
Roger
VL
.
Epidemiology of heart failure: a contemporary perspective
.
Circ Res
.
2021
;
128
(
10
):
1421
34
.
16.
Kass
DA
,
Kitzman
DW
,
Alvarez
GE
.
The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design
.
J Card Fail
.
2010
;
16
(
1
):
17
24
.
17.
Martin-Fernandez
B
,
Gredilla
R
.
Mitochondria and oxidative stress in heart aging
.
Heart Aging Age (Dordr)
.
2016
;
38
(
4
):
225
38
.
18.
Triposkiadis
F
,
Xanthopoulos
A
,
Butler
J
.
Cardiovascular aging and heart failure: JACC review topic of the week
.
J Am Coll Cardiol
.
2019
;
74
(
6
):
804
13
.
19.
Pfeffer
MA
,
Shah
AM
,
Borlaug
BA
.
Heart failure with preserved ejection fraction in perspective
.
Circ Res
.
2019
;
124
(
11
):
1598
617
.
20.
Shah
SJ
,
Borlaug
BA
,
Kitzman
DW
,
McCulloch
AD
,
Blaxall
BC
,
Agarwal
R
, et al
.
Research priorities for heart failure with preserved ejection fraction: national heart, lung, and blood Institute working group summary
.
Circulation
.
2020
;
141
(
12
):
1001
26
.
21.
Chade
AR
,
Eirin
A
.
Cardiac micro-RNA and transcriptomic profile of a novel swine model of chronic kidney disease and left ventricular diastolic dysfunction
.
Am J Physiol Heart Circ Physiol
.
2022
;
323
(
4
):
H659
69
.
22.
Chade
AR
,
Engel
JE
,
Hall
ME
,
Eirin
A
,
Bidwell
GL
3rd
.
Intrarenal modulation of NF-κB activity attenuates cardiac injury in a swine model of CKD: a renal-cardio axis
.
Am J Physiol Ren Physiol
.
2021
;
321
(
4
):
F411
23
.
23.
Chade
AR
,
Williams
ML
,
Engel
J
,
Guise
E
,
Harvey
TW
.
A translational model of chronic kidney disease in swine
.
Am J Physiol Ren Physiol
.
2018
;
315
(
2
):
F364
73
.
24.
Chade
AR
,
Rodriguez-Porcel
M
,
Grande
JP
,
Krier
JD
,
Lerman
A
,
Romero
JC
, et al
.
Distinct renal injury in early atherosclerosis and renovascular disease
.
Circulation
.
2002
;
106
(
9
):
1165
71
.
25.
Eirin
A
,
Chade
AR
.
Cardiac epigenetic changes in VEGF signaling genes associate with myocardial microvascular rarefaction in experimental chronic kidney disease
.
Am J Physiol Heart Circ Physiol
.
2023
;
324
(
1
):
H14
25
.
26.
Chade
AR
,
Eirin
A
.
Cardiac micro-RNA and transcriptomic profile of a novel swine model of chronic kidney disease and left ventricular diastolic dysfunction
.
Am J Physiol Heart Circ Physiol
.
2022
;
323
(
4
):
H659
69
.
27.
Chade
AR
,
Rodriguez-Porcel
M
,
Grande
JP
,
Zhu
X
,
Sica
V
,
Napoli
C
, et al
.
Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis
.
Arterioscler Thromb Vasc Biol
.
2003
;
23
(
7
):
1295
301
.
28.
Chade
AR
,
Tullos
NA
,
Harvey
TW
,
Mahdi
F
,
Bidwell
GL
3rd
.
Renal therapeutic angiogenesis using a bioengineered polymer-stabilized vascular endothelial growth factor construct
.
J Am Soc Nephrol
.
2016
;
27
(
6
):
1741
52
.
29.
Daghini
E
,
Primak
AN
,
Chade
AR
,
Krier
JD
,
Zhu
XY
,
Ritman
EL
, et al
.
Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT
.
Radiology
.
2007
;
243
(
2
):
405
12
.
30.
Chade
AR
,
Sitz
R
,
Kelty
TJ
,
McCarthy
E
,
Tharp
DL
,
Rector
RS
, et al
.
Chronic kidney disease and left ventricular diastolic dysfunction (CKD-LVDD) alter cardiac expression of mitochondria-related genes in swine
.
Transl Res
.
2024
;
267
:
67
78
.
31.
Engel
JE
,
Williams
E
,
Williams
ML
,
Bidwell
GL
3rd
,
Chade
AR
.
Targeted VEGF (vascular endothelial growth factor) therapy induces long-term renal recovery in chronic kidney disease via macrophage polarization
.
Hypertension
.
2019
;
74
(
5
):
1113
23
.
32.
Yuan
F
,
Hedayat
AF
,
Ferguson
CM
,
Lerman
A
,
Lerman
LO
,
Eirin
A
.
Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome
.
Am J Physiol Heart Circ Physiol
.
2018
;
314
(
3
):
H669
80
.
33.
Zhang
X
,
Gibson
ME
,
Li
ZL
,
Zhu
XY
,
Jordan
KL
,
Lerman
A
, et al
.
Autophagy portends the level of cardiac hypertrophy in experimental hypertensive swine model
.
Am J Hypertens
.
2016
;
29
(
1
):
81
9
.
34.
Eirin
A
,
Li
Z
,
Zhang
X
,
Krier
JD
,
Woollard
JR
,
Zhu
XY
, et al
.
A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis
.
Hypertension
.
2012
;
60
(
5
):
1242
9
.
35.
Nangaku
M
,
Alpers
CE
,
Pippin
J
,
Shankland
SJ
,
Kurokawa
K
,
Adler
S
, et al
.
CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats
.
J Am Soc Nephrol
.
1998
;
9
(
4
):
590
7
.
36.
Sweeney
M
,
O’Fee
K
,
Villanueva-Hayes
C
,
Rahman
E
,
Lee
M
,
Vanezis
K
, et al
.
Cardiomyocyte-restricted expression of IL11 causes cardiac fibrosis, inflammation, and dysfunction
.
Int J Mol Sci
.
2023
;
24
(
16
):
12989
.
37.
Wu
L
,
Iwai
M
,
Nakagami
H
,
Chen
R
,
Suzuki
J
,
Akishita
M
, et al
.
Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice
.
Arterioscler Thromb Vasc Biol
.
2002
;
22
:
49
54
.
38.
Eirin
A
,
Zhu
XY
,
Jonnada
S
,
Lerman
A
,
van Wijnen
AJ
,
Lerman
LO
.
Mesenchymal stem cell-derived extracellular vesicles improve the renal microvasculature in metabolic renovascular disease in swine
.
Cell Transpl
.
2018
;
27
(
7
):
1080
95
.
39.
Ward
WK
,
Quinn
MJ
,
Wood
MD
,
Tiekotter
KL
,
Pidikiti
S
,
Gallagher
JA
.
Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)
.
Biosens Bioelectron
.
2003
;
19
(
3
):
155
63
.
40.
Dong
MH
,
Bettencourt
R
,
Brenner
DA
,
Barrett-Connor
E
,
Loomba
R
.
Serum levels of alanine aminotransferase decrease with age in longitudinal analysis
.
Clin Gastroenterol Hepatol
.
2012
;
10
(
3
):
285
90.e1
.
41.
Afarideh
M
,
Zhang
X
,
Ferguson
CM
,
Glockner
JF
,
Lerman
A
,
Textor
SC
, et al
.
Peristenotic collateral circulation in atherosclerotic renovascular disease: association with kidney function and response to treatment
.
Hypertension
.
2020
;
76
(
2
):
497
505
.
42.
Brouwers
FP
,
de Boer
RA
,
van der Harst
P
,
Voors
AA
,
Gansevoort
RT
,
Bakker
SJ
, et al
.
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
.
Eur Heart J
.
2013
;
34
(
19
):
1424
31
.
43.
Chia
CW
,
Egan
JM
,
Ferrucci
L
.
Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk
.
Circ Res
.
2018
;
123
(
7
):
886
904
.
44.
Shen
X
,
Wang
C
,
Zhou
X
,
Zhou
W
,
Hornburg
D
,
Wu
S
, et al
.
Nonlinear dynamics of multi-omics profiles during human aging
.
Nat Aging
.
2024
;
4
(
11
):
1619
34
.
45.
Hoffman
JM
,
Valencak
TG
.
A short life on the farm: aging and longevity in agricultural, large-bodied mammals
.
Geroscience
.
2020
;
42
(
3
):
909
22
.
46.
Chiang
CH
,
Li
SJ
,
Zhang
TR
,
Chen
CY
.
Long-term dietary restriction ameliorates ageing-related renal fibrosis in male mice by normalizing mitochondrial functions and autophagy
.
Biogerontology
.
2022
;
23
(
6
):
731
40
.
47.
Chade
AR
.
Small vessels, big role: renal microcirculation and progression of renal injury
.
Hypertension
.
2017
;
69
(
4
):
551
63
.
48.
Chade
AR
.
Renal vascular structure and rarefaction
.
Compr Physiol
.
2013
;
3
(
2
):
817
31
.
49.
Chade
AR
,
Williams
ML
,
Guise
E
,
Vincent
LJ
,
Harvey
TW
,
Kuna
M
, et al
.
Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease
.
Kidney Int
.
2018
;
93
(
4
):
842
54
.
50.
Ehling
J
,
Babickova
J
,
Gremse
F
,
Klinkhammer
BM
,
Baetke
S
,
Knuechel
R
, et al
.
Quantitative micro-computed tomography imaging of vascular dysfunction in progressive kidney diseases
.
J Am Soc Nephrol
.
2016
;
27
(
2
):
520
32
.
51.
van der Weijden
J
,
De Hoogt
PA
,
Leufkens
MME
,
Keijbeck
AA
,
van Goor
H
,
van den Heuvel
MC
, et al
.
The relationship of peritubular capillary density with glomerular volume and kidney function in living kidney donors
.
J Nephrol
.
2023
;
36
(
7
):
2111
24
.
52.
Hodgkins
KS
,
Schnaper
HW
.
Tubulointerstitial injury and the progression of chronic kidney disease
.
Pediatr Nephrol
.
2012
;
27
(
6
):
901
9
.
53.
Cheng
S
,
Fernandes
VR
,
Bluemke
DA
,
McClelland
RL
,
Kronmal
RA
,
Lima
JA
.
Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis
.
Circ Cardiovasc Imaging
.
2009
;
2
(
3
):
191
8
.
54.
Lelovas
PP
,
Kostomitsopoulos
NG
,
Xanthos
TT
.
A comparative anatomic and physiologic overview of the porcine heart
.
J Am Assoc Lab Anim Sci
.
2014
;
53
(
5
):
432
8
.
55.
Sabbatini
AR
,
Kararigas
G
.
Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week
.
J Am Coll Cardiol
.
2020
;
75
(
9
):
1074
82
.
56.
Lammers
AE
,
Apitz
C
,
Michel-Behnke
I
,
Koestenberger
M
.
A guide to echocardiographic assessment in children and adolescents with pulmonary hypertension
.
Cardiovasc Diagn Ther
.
2021
;
11
(
4
):
1160
77
.
57.
Quaggin
SE
,
Magod
B
.
A united vision for cardiovascular-kidney-metabolic health
.
Nat Rev Nephrol
.
2024
;
20
(
5
):
273
4
.
58.
Ndumele
CE
,
Rangaswami
J
,
Chow
SL
,
Neeland
IJ
,
Tuttle
KR
,
Khan
SS
, et al
.
Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association
.
Circulation
.
2023
;
148
(
20
):
1606
35
.
59.
Aggarwal
R
,
Ostrominski
JW
,
Vaduganathan
M
.
Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020
.
JAMA
.
2024
;
331
(
21
):
1858
60
.
You do not currently have access to this content.